Results 91 to 100 of about 364,087 (292)

Graves’ disease post-COVID-19 m-RNA vaccine in pediatric age group [PDF]

open access: yesAsia Oceania Journal of Nuclear Medicine and Biology
The surge of the COVID-19 pandemic (December / 2019 - May/2023) and its catastrophic effect worldwide have necessitated emergent intervention to reduce its influence on people's health and life.
Abhaa Al-Jahhafi   +3 more
doaj   +1 more source

A Sacrificial 3D Printed Vessel‐on‐Chip Demonstrates a Versatile Approach to Model Granulation Tissue

open access: yesAdvanced Healthcare Materials, EarlyView.
A novel method that combines 3D printing and organ‐on‐chip technology enables the creation of hollow channels lined with endothelial cells through a fibroblast‐populated connective tissue matrix. The model supports stable metabolic culture conditions, angiogenic sprouting, and immune cell migration, thereby demonstrating an easy and versatile method to
Jonas Jäger   +7 more
wiley   +1 more source

Neonatal Graves’ disease from high maternal TRAB antibody levels despite definitive therapy

open access: yesJournal of Clinical and Translational Endocrinology Case Reports
Background: Graves’ disease is an autoimmune thyroid disorder that poses significant risks during pregnancy, affecting both the mother and fetus. Case presentation: We present four cases of neonatal Graves' disease arising in the offspring of two women ...
Dalal S. Ali   +4 more
doaj   +1 more source

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

open access: yesAdvanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao   +2 more
wiley   +1 more source

Safety of different types of methylprednisolone puls-therapy in the treatment of Graves' orbitopathy

open access: yesКлиническая и экспериментальная тиреоидология, 2012
According to the EUGOGO’s (European Group On Graves' Orbitopathy) last consensus, the treatment of choice for Graves’ Orbitopathy (GO) is pulses of glucocorticoid (GC). There is a lack of evidence for superiority of any intravenous (iv) GC schedules.

doaj   +1 more source

Impact of paracetamol pack size restrictions on poisoning from paracetamol in England and Wales: an observational study.

open access: yes, 2005
BACKGROUND: About 500 drug poisoning deaths involving paracetamol (acetaminophen) occur every year in England and Wales. To reduce the number of deaths, regulations were introduced in 1998 to restrict the sale of paracetamol.
Griffiths, Clare   +2 more
core   +1 more source

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

open access: yesAdvanced Healthcare Materials, EarlyView.
Centralizes the microbiome within 3D tumor‐microbiome model platforms, including spheroids, organoids, 3D‐bioprinted constructs, and microfluidic chips, each enabling structured host‐tumor‐microbe studies. These systems support bacterial colonization, facilitating investigation of microbial impacts on tumor growth, immunity, and therapy. The microbiome
Marina Green Buzhor   +12 more
wiley   +1 more source

Focal Spot, Spring 2008 [PDF]

open access: yes, 2008
https://digitalcommons.wustl.edu/focal_spot_archives/1108/thumbnail ...

core   +1 more source

Methotrexate‐Loaded Liposomal Formulation Enables 6‐Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model

open access: yesAdvanced Healthcare Materials, EarlyView.
A liposomal formulation for methotrexate enables minimally invasive, sustained intraocular drug delivery for over six weeks with a single injection. Developed for treating intraocular diseases like lymphoma and PVR, it offers excellent biocompatibility in vivo in a porcine model.
Maximilian Hammer   +17 more
wiley   +1 more source

Association of PTPN22 Haplotypes with Hashimotos Thyroiditis in Population of Novosibirsk

open access: yesКлиническая и экспериментальная тиреоидология, 2009
The single nucleotide polymorphism (SNP) C1858T within the PTPN22 gene was recently associated with autoimmune thyroid disease (AITD). The purpose of this study was to examine the joint association of this polymorphism with the AITD.

doaj   +1 more source

Home - About - Disclaimer - Privacy